Why the study?
The study aimed to develop and externally validate a coronary heart disease risk model from routine clinical indicators and identify key predictors.
Does a machine learning model based on simple physical examination parameters accurately predict coronary heart disease risk?
Does a machine learning model based on simple physical examination parameters accurately predict coronary heart disease risk?
A stacked ensemble machine learning model built from routinely available clinical parameters demonstrated excellent discrimination and robust external generalizability for predicting coronary heart disease risk, outperforming traditional risk scores.
Answers are grounded in this paper and cite their sources.
May support routine-data CHD risk stratification; leaves open prospective validation before clinical use.
Background To develop and externally validate a coronary heart disease (CHD) risk model from routine clinical indicators and identify key predictors. Methods The Framingham Heart Study cohort ( n = 4,240) was used. Missing values and outliers were handled, and class imbalance was corrected with SMOTEENN/SMOTETomek. Data were split 7:3 for training and internal validation. A two-tier feature selection (chi-square, mutual information, ANOVA F -test) retained ten variables. A stacked ensemble of gradient boosting, random forest, and XGBoost with a logistic-regression meta-learner was trained. Performance was measured by AUC, accuracy, precision, recall, and F 1. External validation used a retrospective hospital cohort ( n = 200; 2024–2025). Model explanations were derived with SHAP. Results Internal validation yielded AUC 0.977 and accuracy 0.942 ( F 1: 0.944). External validation achieved AUC 0.929 and accuracy 0.885. SHAP identified systolic blood pressure, age, total cholesterol, and fasting glucose as leading contributors, with plausible nonlinear effects and interactions. Conclusion A model built from routinely available measures demonstrates strong discrimination for CHD risk and generalizes to an external cohort, offering a clinically interpretable tool for cardiovascular risk assessment.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: